Volume 6, Number 3—June 2000
Costs and Benefits of a Subtype-Specific Surveillance System for Identifying Escherichia coli O157:H7 Outbreaks
|Labor and equipment costs||Total costs||Escherichia coli-related costsa|
|Laboratory scientist (per year)b||$10,000||$4,000|
|Analyzing the isolates (per year)c||$12,000||$12,000|
|Investigating an outbreakd,e||$9,600||$9,600|
|Present value of outbreak costs (in 5 years)f||$90,568||$90,568|
|Annual operating costsg||$41,200||$35,520|
aFrom the proportion of E. coli isolates among the total number of isolates expected to be subtyped each year, we extrapolated that 40% of the equipment and labor costs were E. coli-related.
bThe salary and fringe benefits of a full-time laboratory analyst.
cAnalyzing 300 isolates at a cost of $40 per isolate.
dThis cost included, but was not limited to, the value of time (15 days) spent investigating an outbreak, answering telephone calls, conducting meetings, improving and transferring pulsed-field gel electrophoresis image files to various groups, creating databases, requesting information, responding to media calls, and handling legal issues. We assumed that, as a result of the system, two outbreaks would be investigated each year (6).
eThe costs of additional labor and the epidemiologic investigation of an outbreak were estimated at $5,000 and $4,600, respectively.
fAt a discount rate of 3%.
gLaboratory scientist ($10,000) + analyzing the isolates ($12,000) + investigating two outbreaks (2 x $9,600 = $19,200)
- Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991;13:60–98.
- American Gastroenterological Association. Consensus statement: Escherichia coli O157:H7 infections: an emerging national health crisis, July 11-13, 1994. Gastroenterology. 1995;108:1923–34.
- Roberts T, Buzby J, Lin J, Mead P, Nunnery P, Tarr PI. Economic aspects of E. coli O157:H7: disease outcome trees, risk, uncertainty, and social cost of disease estimates. In: Prediction, detection, and management of tomorrow's epidemics. Greenwood B, De Cock K, eds. John Wiley & Sons, Chichester, UK. pp 156-72.
- Buzby JC, Roberts T, Lin JC-T, MacDonald JM. Bacterial foodborne disease: medical costs and productivity losses. Washington: U.S. Department of Agriculture, Economic Research Service. AER No. 741. August 1996.
- Centers for Disease Control and Prevention. Preliminary report: foodborne outbreak of Escherichia coli O157:H7 infections from hamburgers--western United States, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:85–6.
- Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. Surveillance for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med. 1997;337:388–94.
- Kolata G. Detective work and science reveal a new lethal bacteria. New York Times. 1998 Jan 6;147:A1, A14.
- Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, A multiple outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington State experience. JAMA. 1994;272:1349–53.
- Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. A guide to decision analysis and economic evaluation. New York: Oxford University Press; 1996.
- Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
- Landefeld JS, Seskin EP. The economic value of life: linking theory to practice. Am J Public Health. 1982;6:555–66.
- Centers for Disease Control and Prevention. Enhanced detection of sporadic Escherichia coli O157:H7 infections--New Jersey, July, 1994. MMWR Morb Mortal Wkly Rep. 1993;44:417–8.
- Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1998. MMWR Morb Mortal Wkly Rep. 1999;47:1–93.